Saldarriaga, Enrique M
Cárcamo, Cesar P.
Babigumira, Joseph B.
García, Patricia J.
Funding for this research was provided by:
Merck & Co., Inc., Kenilworth, NJ
Article History
Received: 1 June 2021
Accepted: 1 October 2021
First Online: 14 October 2021
Declarations
:
: The protocol and instruments were reviewed and approved by the IRB of the Universidad Peruana Cayetano Heredia (# 65616). All protocols are carried out in accordance with relevant guidelines and regulations. Participants were aware of the study and understood the benefits and risks involved. Informed consent was obtained from all participants.
: Not applicable.
: Merck & Co., Inc., produces Gardasil 4-valent HPV vaccine however, the funder had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. The authors have no competing interest to declare.